New combo therapy aims to shield preemie lungs from chronic damage

NCT ID NCT06855043

First seen Nov 15, 2025 · Last updated Apr 28, 2026 · Updated 25 times

Summary

This study tests whether giving a lung medication (surfactant mixed with budesonide) to extremely preterm babies who are still on a breathing machine at 7-14 days old can help prevent a serious lung condition called bronchopulmonary dysplasia. About 24 infants will be enrolled to check for immediate safety issues like drops in oxygen or heart rate, and to see if their breathing improves. The goal is to find a way to protect fragile lungs and reduce long-term breathing problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE MECHANICAL VENTILATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • American Family Children's Hospital

    Madison, Wisconsin, 53792, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Meriter Hospital

    Madison, Wisconsin, 53715, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.